help button home button Endocrine Society Molecular Endocrinology ENDO 08 Sessions Library
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Qian, H.
Right arrow Articles by Thomas, W. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Qian, H.
Right arrow Articles by Thomas, W. G.
Molecular Endocrinology 15 (10): 1706-1719
Copyright © 2001 by The Endocrine Society

Association of ß-Arrestin 1 with the Type 1A Angiotensin II Receptor Involves Phosphorylation of the Receptor Carboxyl Terminus and Correlates with Receptor Internalization

Hongwei Qian, Luisa Pipolo and Walter G. Thomas

Molecular Endocrinology Laboratory, Baker Medical Research Institute, Melbourne 8008, Australia

Address all correspondence and requests for reprints to: Dr. Walter G. Thomas, Molecular Endocrinology Laboratory, Baker Medical Research Institute, PO Box 6492, St. Kilda Road Central, Melbourne Victoria 8008, Australia. E-mail: walter.thomas{at}baker.edu.au

Arrestins bind to phosphorylated G protein-coupled receptors and participate in receptor desensitization and endocytosis. Although arrestins traffic with activated type 1 (AT1A) angiotensin II (AngII) receptors, the contribution of arrestins to AT1A receptor internalization is controversial, and the physical association of arrestins with the AT1A receptor has not been established. In this study, by coimmunoprecipitating AT1A receptors and ß-arrestin 1, we provide direct evidence for an association between arrestins and the AT1A receptor that was agonist- and time-dependent and contingent upon the level of ß-arrestin 1 expression. Serial truncation of the receptor carboxyl terminus resulted in a graded loss of ß-arrestin 1 association, which correlated with decreases in receptor phosphorylation. Truncation of the AT1A receptor to lysine325 prevented AngII-induced phosphorylation and ß-arrestin 1 association as well as markedly inhibiting receptor internalization, indicating a close correlation between these receptor parameters. AngII-induced association was also dramatically reduced in a phosphorylation- and internalization-impaired receptor mutant in which four serine and threonine residues in the central portion of the AT1A receptor carboxyl terminus (Thr332, Ser335, Thr336, Ser338) were substituted with alanine. In contrast, substitutions in another serine/threonine-rich region (Ser346, Ser347, Ser348) and at three PKC phosphorylation sites (Ser331, Ser338, Ser348) had no effect on AngII-induced ß-arrestin 1 association or receptor internalization. While AT1A receptor internalization could be inhibited by a dominant-negative ß-arrestin 1 mutant (ßarr1319–418), treatment with hyperosmotic sucrose to inhibit internalization did not abrogate the differences in arrestin association observed between the wild-type and mutant receptors, indicating that arrestin binding precedes, and is not dependent upon, receptor internalization. Interestingly, a substituted analog of AngII, [Sar1Ile4Ile8]-AngII, which promotes robust phosphorylation of the receptor but does not activate receptor signaling, stimulated strong ß-arrestin 1 association with the full-length AT1A receptor. These results identify the central portion of the AT1A receptor carboxyl terminus as the important determinant for ß-arrestin 1 binding and internalization and indicate that AT1A receptor phosphorylation is crucial for ß-arrestin docking.




This article has been cited by other articles:


Home page
J Biomol ScreenHome page
M. Vrecl, P. K. Norregaard, D. L.C. Almholt, L. Elster, A. Pogacnik, and A. Heding
{beta}-Arrestin-Based Bret2 Screening Assay for the "Non"-{beta}-Arrestin Binding CB1 Receptor
J Biomol Screen, April 1, 2009; 14(4): 371 - 380.
[Abstract] [PDF]


Home page
Mol. Pharmacol.Home page
H. Lan, Y. Liu, M. I. Bell, V. V. Gurevich, and K. A. Neve
A Dopamine D2 Receptor Mutant Capable of G Protein-Mediated Signaling but Deficient in Arrestin Binding
Mol. Pharmacol., January 1, 2009; 75(1): 113 - 123.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
M. Szaszak, H.-D. Chen, H.-C. Chen, A. Baukal, L. Hunyady, and K. J Catt
Identification of the invariant chain (CD74) as an angiotensin AGTR1-interacting protein
J. Endocrinol., November 1, 2008; 199(2): 165 - 176.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Lee, S. Bhatt, A. Shukla, R. W. Desnoyer, S. P. Yadav, M. Kim, S.-H. Jang, and S. S. Karnik
Site-specific Cleavage of G Protein-coupled Receptor-engaged {beta}-Arrestin: INFLUENCE OF THE AT1 RECEPTOR CONFORMATION ON SCISSILE SITE SELECTION
J. Biol. Chem., August 1, 2008; 283(31): 21612 - 21620.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
K. Thieme, D. M. N. Eguti, M. Mello-Aires, and M. Oliveira-Souza
The effect of angiotensin II on intracellular pH is mediated by AT1 receptor translocation
Am J Physiol Cell Physiol, July 1, 2008; 295(1): C138 - C145.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
E. Peverelli, G. Mantovani, D. Calebiro, A. Doni, S. Bondioni, A. Lania, P. Beck-Peccoz, and A. Spada
The Third Intracellular Loop of the Human Somatostatin Receptor 5 Is Crucial for Arrestin Binding and Receptor Internalization after Somatostatin Stimulation
Mol. Endocrinol., March 1, 2008; 22(3): 676 - 688.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. D. Violin, S. M. DeWire, W. G. Barnes, and R. J. Lefkowitz
G Protein-coupled Receptor Kinase and beta-Arrestin-mediated Desensitization of the Angiotensin II Type 1A Receptor Elucidated by Diacylglycerol Dynamics
J. Biol. Chem., November 24, 2006; 281(47): 36411 - 36419.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
J. A. Olivares-Reyes, B. H. Shah, J. Hernandez-Aranda, A. Garcia-Caballero, M. P. Farshori, J. A. Garcia-Sainz, and K. J. Catt
Agonist-Induced Interactions between Angiotensin AT1 and Epidermal Growth Factor Receptors
Mol. Pharmacol., August 1, 2005; 68(2): 356 - 364.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. L. Estall, J. A. Koehler, B. Yusta, and D. J. Drucker
The Glucagon-like Peptide-2 Receptor C Terminus Modulates {beta}-Arrestin-2 Association but Is Dispensable for Ligand-induced Desensitization, Endocytosis, and G-protein-dependent Effector Activation
J. Biol. Chem., June 10, 2005; 280(23): 22124 - 22134.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
D. T. Dinh, H. Qian, R. Seeber, E. Lim, K. Pfleger, K. A. Eidne, and W. G. Thomas
Helix I of {beta}-Arrestin Is Involved in Postendocytic Trafficking but Is Not Required for Membrane Translocation, Receptor Binding, and Internalization
Mol. Pharmacol., February 1, 2005; 67(2): 375 - 382.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Wei, S. Ahn, W. G. Barnes, and R. J. Lefkowitz
Stable Interaction between {beta}-Arrestin 2 and Angiotensin Type 1A Receptor Is Required for {beta}-Arrestin 2-mediated Activation of Extracellular Signal-regulated Kinases 1 and 2
J. Biol. Chem., November 12, 2004; 279(46): 48255 - 48261.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
A. SPAT and L. HUNYADY
Control of Aldosterone Secretion: A Model for Convergence in Cellular Signaling Pathways
Physiol Rev, April 1, 2004; 84(2): 489 - 539.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart J SupplHome page
G. Jennings
New definitions in cardiovascular risk management: is it time for angiotensin II receptor blockers to become first-line medication?
Eur. Heart J. Suppl., August 1, 2003; 5(suppl_F): F3 - F11.
[Abstract] [PDF]


Home page
HypertensionHome page
P. V. Escriba, J. M. Sanchez-Dominguez, R. Alemany, J. S. Perona, and V. Ruiz-Gutierrez
Alteration of Lipids, G Proteins, and PKC in Cell Membranes of Elderly Hypertensives
Hypertension, January 1, 2003; 41(1): 176 - 182.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
F. Huttenrauch, A. Nitzki, F.-T. Lin, S. Honing, and M. Oppermann
beta -Arrestin Binding to CC Chemokine Receptor 5 Requires Multiple C-terminal Receptor Phosphorylation Sites and Involves a Conserved Asp-Arg-Tyr Sequence Motif
J. Biol. Chem., August 16, 2002; 277(34): 30769 - 30777.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
L. Hunyady, A. J. Baukal, Z. Gaborik, J. A. Olivares-Reyes, M. Bor, M. Szaszak, R. Lodge, K. J. Catt, and T. Balla
Differential PI 3-kinase dependence of early and late phases of recycling of the internalized AT1 angiotensin receptor
J. Cell Biol., June 24, 2002; 157(7): 1211 - 1222.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Szaszak, Z. Gaborik, G. Turu, P. S. McPherson, A. J. L. Clark, K. J. Catt, and L. Hunyady
Role of the Proline-rich Domain of Dynamin-2 and Its Interactions with Src Homology 3 Domains during Endocytosis of the AT1 Angiotensin Receptor
J. Biol. Chem., June 7, 2002; 277(24): 21650 - 21656.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Kishi, H. Krishnamurthy, C. Galet, R. S. Bhaskaran, and M. Ascoli
Identification of a Short Linear Sequence Present in the C-terminal Tail of the Rat Follitropin Receptor That Modulates Arrestin-3 Binding in a Phosphorylation-independent Fashion
J. Biol. Chem., June 7, 2002; 277(24): 21939 - 21946.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Min, C. Galet, and M. Ascoli
The Association of Arrestin-3 with the Human Lutropin/Choriogonadotropin Receptor Depends Mostly on Receptor Activation Rather than on Receptor Phosphorylation
J. Biol. Chem., January 4, 2002; 277(1): 702 - 710.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2001 by The Endocrine Society